Myriad Genetics, Tufts Health Plan Sign 3-Year Contract to Cover Prolaris for Members With Localized Prostate Cancer
October 07, 2015 at 07:07 AM EDT
Myriad Genetics, Inc. (NASDAQ: MYGN) today announced that it has signed a three-year contract with Tufts Health Plan through which the ...
